Clinical Trials on Neoplasms, Liver in Australia

Total 5345 results

Otto Wagner Hospital
Medtronic Spine LLC

Recruiting

Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy

Lung Neoplasm Malignant

Austria
University of Sydney

Recruiting

Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging (MAGIK)

Lung Cancer

Australia
Cellxpert Biotechnology Corp.
Medigen Biotechnology Corporation

Completed

PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma

Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)

Australia, United States
Verastem, Inc.

Completed

Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms

Prostatic Neoplasm | Pancreatic Neoplasm | Head and Neck Neoplasm

United States, Australia, Canada
Australasian Gastro-Intestinal Trials Group
Canadian Cancer Trials Group

Not yet recruiting

Cessation of Somatostatin Analogues After PRRT in Mid-Gut Neuroendocrine Tumours (STOPNET)

Neuroendocrine Tumors

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)

Neuroendocrine Tumors

Australia
Ludwig Institute for Cancer Research
Pfizer; Heidelberg Pharma AG

Terminated

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma (RCC)

Australia
University of Dundee
Burnet Institute; Public Health Wales

Completed

Reaching mEthadone Users Attending Community pHarmacies With HCV (REACH HCV)

Hepatitis C

Australia, United Kingdom
St Vincent's Hospital Melbourne
National Health and Medical Research Council, Australia

Unknown

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients (STOP)

Chronic Hepatitis B.

Australia
Trans Tasman Radiation Oncology Group

Completed

Chemoradiation Treatment for Head and Neck Cancer

Head and Neck Cancer

Australia
Olivia Newton-John Cancer Research Institute
Merck Sharp & Dohme LLC; Viralytics

Active, not recruiting

Pembrolizumab + CVA21 in Advanced NSCLC

Non-Small Cell Lung Cancer

Australia
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Carcinoma, Hepatocellular

United States, Australia, Canada, Chile, China, Colombia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom
Austin Health

Completed

Endoscopy-related Phone Consultation During the COVID-19 Outbreak

Reflux, Gastroesophageal | Colon Disease | Colon Polyp | Varices, Esophageal

Australia
National University Hospital, Singapore
KK Women's and Children's Hospital; National Cancer Centre, Singapore; Australia...

Unknown

Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer

Singapore, Australia
Murdoch Childrens Research Institute
Brockhoff Foundation Australia; Shepherd Foundation Australia

Completed

Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination (HPV)

Cervical Cancer

Australia
Blaze Bioscience Australia Pty Ltd

Completed

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Skin Neoplasms

Australia
Olivia Newton-John Cancer Research Institute
Austin Health; Merck Healthcare KGaA

Terminated

Bioimaging Study of 89Zr-M7824 in NSCLC

Non-Small Cell Lung Cancer

Australia
Trans Tasman Radiation Oncology Group

Completed

A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer (Local HER-O)

Breast Neoplasms

Australia
Austin Health
Royal North Shore Hospital; Ballarat Health Services; Queen Elizabeth Hospital...

Unknown

Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib (Dux)

Metastatic Colorectal Cancer

Australia
BeiGene

Recruiting

Study of BG-C9074 as Monotherapy and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

Advanced Solid Tumor

Australia
Zhejiang Genfleet Therapeutics Co., Ltd.

Completed

A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China, Australia
Peter MacCallum Cancer Centre, Australia
Endocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation...

Active, not recruiting

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy (LuTectomy)

Prostatic Neoplasms

Australia
Austin Health

Completed

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Prostate Cancer

Australia
Melanoma and Skin Cancer Trials Limited
Monash University

Completed

Improving Skin Cancer Management With Artificial Intelligence (04.17 SMARTI) (SMARTI)

Skin Cancer | Melanoma (Skin)

Australia
Hummingbird Bioscience
Merck KGaA, Darmstadt, Germany

Recruiting

Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Australia, Singapore
Clarity Pharmaceuticals Ltd

Active, not recruiting

A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)

Neuroendocrine Tumors

Australia
Austin Health

Unknown

Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol (RADiChol)

Cholangiocarcinoma

Australia
Peter MacCallum Cancer Centre, Australia

Completed

Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475 (BOSTON II)

Breast Neoplasms | Bone Neoplasms

Australia
Bristol-Myers Squibb

Completed

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Melanoma

Australia
Bristol-Myers Squibb

Completed

A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab

Non-Small Cell Lung Cancer

Australia
Royal Brisbane and Women's Hospital

Completed

Breath Testing in Early and Late Larynx Cancer

Larynx Cancer

Australia
AdvanCell Isotopes Pty Limited

Recruiting

Dose Escalation and Efficacy Study of 212Pb-ADVC001 in Patients With Metastatic Castration Resistant Prostate Cancer.

Prostatic Neoplasms | Castration-Resistant

Australia
Kirby Institute
Bristol-Myers Squibb

Withdrawn

Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism (HEPCOG-II)

Hepatitis C, Chronic

Australia
Kirby Institute

Completed

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection (D3FEAT)

Hepatitis C, Chronic

Australia
University of Sydney
University of Roma La Sapienza; Australasian Bone Marrow Transplant Recipient... and other collaborators

Recruiting

Prophylactic Early PN in HPT/BMT

Hematologic Neoplasms

Australia, New Zealand
Gilead Sciences

Completed

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (CHARM)

Chronic Hepatitis B

Australia
Walter and Eliza Hall Institute of Medical Research
Melbourne Health; Royal Marsden NHS Foundation Trust

Completed

Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours (G3 RPLN PBC)

Testicular Neoplasms

Australia
Novartis Pharmaceuticals

Terminated

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)

Belgium, Australia, United States
Medical University of Vienna

Completed

HaemoCerTM Application in Breast Cancer Surgery

Breast Neoplasm Female | Mastectomy, Segmental

Austria
Atridia Pty Ltd.

Completed

A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer

Prostate Cancer | Neoplasm

Australia
Panbela Therapeutics, Inc.

Completed

Study of SBP-101 in Pancreatic Cancer

Pancreatic Cancer | Ductal Adenocarcinoma of the Pancreas

United States, Australia
Olivia Newton-John Cancer Research Institute
Bristol-Myers Squibb

Active, not recruiting

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Gastrointestinal Cancer | Malignant Female Reproductive System Neoplasm | Neuroendocrine Tumours

Australia
University of Helsinki
Royal Children's Hospital; Murdoch Childrens Research Institute; University of... and other collaborators

Active, not recruiting

Healthcare Transition of Adolescents With Chronic Health Conditions

Liver Diseases | Kidney Diseases | Diabetes | Rheumatic Diseases | Inflammatory Bowel Diseases | Neurologic Disorder | Congenital Heart Disease | Transition

Australia, Finland
Peter MacCallum Cancer Centre, Australia

Completed

High Intensity Functional Image Guided Vmat Lung Evasion (HI-FIVE)

Non Small Cell Lung Cancer Stage III

Australia
Cellaion SA

Active, not recruiting

Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF) (DHELIVER)

Acute on Chronic Liver Failure

Belgium, Spain, France, Austria, Denmark, Latvia, Germany, Bulgaria, Poland, Estonia, Italy, Lithuania, North Macedonia, Slovakia
Queensland Centre of Excellence for Head and Neck...
The University of Queensland; Princess Alexandra Hospital, Brisbane, Australia and other collaborators

Unknown

The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study

Head and Neck Squamous Cell Carcinoma | Human Papillomavirus

Australia
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (ATLAS)

Nonalcoholic Steatohepatitis

Hong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
Peter MacCallum Cancer Centre, Australia

Recruiting

Metabolic Phenotypes in Melanoma (MetaMel)

Melanoma

Australia
Abbott

Completed

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

HIV Infections | Sarcoma, Kaposi

Australia
Peter MacCallum Cancer Centre, Australia
Trans Tasman Radiation Oncology Group

Completed

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer (AZTEC)

Breast Cancer

Australia

Clinical Trials on Neoplasms, Liver in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations